Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries - Provan, Sella Aarrestad; Ljung, Lotta; Kristianslund, Eirik Klami; Michelsen, Brigitte; Uhlig, Till; Jonmundsson, Thorarinn; Sexton, Joe; Gudbjornsson, Bjorn; Di Giuseppe, Daniela; Hetland, Merete Lund; Reynisdottir, Gudrun Bjork; Glintborg, Bente; et al. (Journal of rheumatology, 2024)
Keywords: Adult; Aged; Antirheumatic Agents - adverse effects; Antirheumatic Agents - therapeutic use; Arthritis, Psoriatic - drug therapy; Arthritis, Psoriatic - epidemiology; Arthritis, Rheumatoid - complications; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - epidemiology; Biological Products - adverse effects; Biological Products - therapeutic use; Female; Follow-Up Studies; Humans; Incidence; Lung Diseases, Interstitial - epidemiology; Male; Methotrexate - therapeutic use; Middle Aged; Registries; Scandinavian and Nordic Countries - epidemiology; Scandinavian and Nordic Countries; methotrexate; psoriatic arthritis; interstitial lung disease; rheumatoid arthritis